Literature DB >> 18570169

Evaluation of a urine screen for acetaminophen.

Daniel N Ingram1, George N Bosse, Edward P Womack, Saeed Jortani.   

Abstract

BACKGROUND: Acetaminophen (APAP) is a leading cause of fatal overdose. This study examined the performance characteristics of the Biosite Triage TOX Drug Screen qualitative APAP urine test (urine screen) in a clinical setting.
METHODS: Paired urine and serum waste samples (collected within 2 hours of one another) were quantitatively analyzed for APAP concentration and compared to the urine screen results.
RESULTS: A total of 191 paired samples met inclusion criteria. The urine screen did not report a negative result for the 21 samples with a serum APAP concentration of > or =10microg/mL and had a sensitivity of 100% (95% confidence interval [CI], 85-100%). The urine screen had a sensitivity of 96% (95% CI, 91-99%) and a specificity of 90% (95% CI, 82-95%) for detecting urine APAP concentrations > 5microg/mL by gas chromatograph mass spectroscopy (GCMS) methods, and a sensitivity of 81% (95% CI, 73-87%) and a specificity of 95% (95% CI, 85-98%) by high-pressure liquid chromatography (HPLC) methods.
CONCLUSIONS: The urine screen detected urine APAP concentrations with good accuracy and may be an effective screen to rule out acute APAP overdose in some circumstances. Its clinical utility is discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18570169      PMCID: PMC3550136          DOI: 10.1007/bf03160962

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  6 in total

1.  Acetaminophen poisoning and toxicity.

Authors:  B H Rumack; H Matthew
Journal:  Pediatrics       Date:  1975-06       Impact factor: 7.124

2.  National academy of clinical biochemistry laboratory medicine practice guidelines: recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department.

Authors:  Alan H B Wu; Charles McKay; Larry A Broussard; Robert S Hoffman; Tai C Kwong; Thomas P Moyer; Edward M Otten; Shirley L Welch; Paul Wax
Journal:  Clin Chem       Date:  2003-03       Impact factor: 8.327

3.  Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism.

Authors:  J R Mitchell; D J Jollow; W Z Potter; D C Davis; J R Gillette; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1973-10       Impact factor: 4.030

4.  Acetaminophen and salicylate serum levels in patients with suicidal ingestion or altered mental status.

Authors:  K A Sporer; H Khayam-Bashi
Journal:  Am J Emerg Med       Date:  1996-09       Impact factor: 2.469

5.  Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study.

Authors:  Anne M Larson; Julie Polson; Robert J Fontana; Timothy J Davern; Ezmina Lalani; Linda S Hynan; Joan S Reisch; Frank V Schiødt; George Ostapowicz; A Obaid Shakil; William M Lee
Journal:  Hepatology       Date:  2005-12       Impact factor: 17.425

6.  Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial.

Authors:  R Keays; P M Harrison; J A Wendon; A Forbes; C Gove; G J Alexander; R Williams
Journal:  BMJ       Date:  1991-10-26
  6 in total
  1 in total

1.  Evaluation of the Triage TOX Drug Screen Assay for Detection of 11 Drugs of Abuse and Therapeutic Drugs.

Authors:  Hae In Bang; Mi Ae Jang; Yong Wha Lee
Journal:  Ann Lab Med       Date:  2017-11       Impact factor: 3.464

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.